{"id":"https://openalex.org/W2952907976","doi":"https://doi.org/10.3389/fimmu.2019.01275","title":"Pathogenetic Therapy of Psoriasis by Muramyl Peptide","display_name":"Pathogenetic Therapy of Psoriasis by Muramyl Peptide","alternate_titles":[],"publication_year":2019,"publication_date":"2019-06-20","ids":{"openalex":"https://openalex.org/W2952907976","doi":"https://doi.org/10.3389/fimmu.2019.01275","mag":"2952907976","pmid":"https://pubmed.ncbi.nlm.nih.gov/31281308","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6595465"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2019.01275","doi":"https://doi.org/10.3389/fimmu.2019.01275","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2019.01275","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2019.01275/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2952907976"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2019.01275/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011119815","display_name":"Svetlana V. Guryanova","orcid":"https://orcid.org/0000-0001-6186-2462","observed_orcids":["https://orcid.org/0000-0001-6186-2462"]},"institutions":[{"id":"https://openalex.org/I126527374","display_name":"Peoples' Friendship University of Russia","ror":"https://ror.org/02dn9h927","country_code":"RU","type":"education","lineage":["https://openalex.org/I126527374"]},{"id":"https://openalex.org/I4210105571","display_name":"Institute of Bioorganic Chemistry","ror":"https://ror.org/01dg04253","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210105571","https://openalex.org/I4210129690"]}],"countries":["RU"],"is_corresponding":true,"raw_author_name":"Svetlana Guryanova","raw_affiliation_strings":["AO Peptek, Moscow, Russia","Medical Institute, RUDN University, Moscow, Russia","Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, RAS, Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AO Peptek, Moscow, Russia","institution_ids":[]},{"raw_affiliation_string":"Medical Institute, RUDN University, Moscow, Russia","institution_ids":["https://openalex.org/I126527374"]},{"raw_affiliation_string":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, RAS, Moscow, Russia","institution_ids":["https://openalex.org/I4210105571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056045737","display_name":"Vladislav Yu. Udzhukhu","orcid":"https://orcid.org/0000-0002-3351-9138","observed_orcids":["https://orcid.org/0000-0002-3351-9138"]},"institutions":[{"id":"https://openalex.org/I337778094","display_name":"Pirogov Russian National Research Medical University","ror":"https://ror.org/018159086","country_code":"RU","type":"education","lineage":["https://openalex.org/I337778094","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Vladislav Udzhukhu","raw_affiliation_strings":["Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia","institution_ids":["https://openalex.org/I337778094"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025833995","display_name":"A.A. Kubylinskiy","orcid":"https://orcid.org/0000-0002-4645-8215","observed_orcids":["https://orcid.org/0000-0002-4645-8215"]},"institutions":[{"id":"https://openalex.org/I337778094","display_name":"Pirogov Russian National Research Medical University","ror":"https://ror.org/018159086","country_code":"RU","type":"education","lineage":["https://openalex.org/I337778094","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Aleksandr Kubylinsky","raw_affiliation_strings":["Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia","institution_ids":["https://openalex.org/I337778094"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5011119815"],"corresponding_institution_ids":["https://openalex.org/I126527374","https://openalex.org/I4210105571"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.5017,"has_fulltext":true,"cited_by_count":21,"citation_normalized_percentile":{"value":0.80398671,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"10","issue":null,"first_page":"1275","last_page":"1275"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.8840000033378601},{"id":"https://openalex.org/keywords/muramyl-peptides","display_name":"muramyl peptides","score":0.9950000047683716},{"id":"https://openalex.org/keywords/innate-immunity","display_name":"innate immunity","score":0.8840000033378601},{"id":"https://openalex.org/keywords/cytokines","display_name":"cytokines","score":0.8009999990463257},{"id":"https://openalex.org/keywords/il-4","display_name":"IL-4","score":0.7450000047683716},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.9779999852180481},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9810000061988831},{"id":"https://openalex.org/keywords/sicam-1","display_name":"sICAM-1","score":0.8410000205039978},{"id":"https://openalex.org/keywords/mcp-1","display_name":"MCP-1","score":0.8659999966621399},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.9520000219345093},{"id":"https://openalex.org/keywords/relapse-free-period","display_name":"relapse-free period","score":0.7789999842643738},{"id":"https://openalex.org/keywords/disease-severity-markers","display_name":"disease severity markers","score":0.7559999823570251},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.7630000114440918}],"concepts":[{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.8623065948486328},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.791978120803833},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.7253057956695557},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.535022497177124},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5260210633277893},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4808964729309082},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4661404490470886},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4264403283596039},{"id":"https://openalex.org/C2776444769","wikidata":"https://www.wikidata.org/wiki/Q259464","display_name":"Muramyl dipeptide","level":3,"score":0.4214155673980713},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.4142473042011261},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.355243057012558}],"mesh":[{"descriptor_ui":"D000119","descriptor_name":"Acetylmuramyl-Alanyl-Isoglutamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018799","descriptor_name":"Intercellular Adhesion Molecule-1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018799","descriptor_name":"Intercellular Adhesion Molecule-1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.3389/fimmu.2019.01275","doi":"https://doi.org/10.3389/fimmu.2019.01275","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2019.01275","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2019.01275/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5576850","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6595465","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:31281308","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31281308","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Clinical Trial"},{"id":"pmh:oai:pubmedcentral.nih.gov:6595465","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6595465/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:68574e78730a4c06a3fb4dd0420992a7","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/68574e78730a4c06a3fb4dd0420992a7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 10 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2019.01275","doi":"https://doi.org/10.3389/fimmu.2019.01275","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2019.01275","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2019.01275/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324099","display_name":"Russian Science Foundation","ror":"https://ror.org/03y2gwe85"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2952907976.pdf","grobid_xml":"https://content.openalex.org/works/W2952907976.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W368372511","https://openalex.org/W615464917","https://openalex.org/W1514224413","https://openalex.org/W1782747004","https://openalex.org/W1968746320","https://openalex.org/W1975408659","https://openalex.org/W1980009004","https://openalex.org/W1992163061","https://openalex.org/W2001166572","https://openalex.org/W2001590535","https://openalex.org/W2008493138","https://openalex.org/W2008702602","https://openalex.org/W2018542503","https://openalex.org/W2021018799","https://openalex.org/W2054186726","https://openalex.org/W2057790293","https://openalex.org/W2070405472","https://openalex.org/W2091677698","https://openalex.org/W2100023645","https://openalex.org/W2103120331","https://openalex.org/W2107590832","https://openalex.org/W2144831969","https://openalex.org/W2227866787","https://openalex.org/W2323903826","https://openalex.org/W2463492818","https://openalex.org/W2523593356","https://openalex.org/W2524572457","https://openalex.org/W2528686571","https://openalex.org/W2549301880","https://openalex.org/W2561759163","https://openalex.org/W2561777447","https://openalex.org/W2604181452","https://openalex.org/W2606443041","https://openalex.org/W2753284469","https://openalex.org/W2757347075","https://openalex.org/W2769068226","https://openalex.org/W2788122371","https://openalex.org/W2792528757","https://openalex.org/W2801383608","https://openalex.org/W2811171873","https://openalex.org/W2816275954","https://openalex.org/W2888446574","https://openalex.org/W2895410266","https://openalex.org/W6619026735"],"related_works":["https://openalex.org/W3134173568","https://openalex.org/W2038449211","https://openalex.org/W2038923911","https://openalex.org/W4414397788","https://openalex.org/W2135538358","https://openalex.org/W7005289510","https://openalex.org/W2049045908","https://openalex.org/W2017434692","https://openalex.org/W2407204164","https://openalex.org/W4318499553"],"abstract_inverted_index":{"Psoriasis":[0,63],"is":[1],"a":[2,6,101,123,206],"multifactorial":[3],"disease":[4,148],"with":[5,44,54,151,172,233,253],"dysregulation":[7],"in":[8,42,76,112,155,160,205,248,272],"immune":[9,199],"system.":[10],"The":[11,46,62,166],"aim":[12],"of":[13,24,30,33,48,57,73,83,89,91,103,114,146,163,179,184,197,209,231,241,251,259,262,276],"this":[14],"study":[15],"was":[16,60,94,110],"to":[17,218],"survey":[18],"the":[19,28,31,80,97,104,147,161,176,182,198,229,249,260,274,277],"clinical":[20,106,177],"efficacy":[21],"and":[22,65,71,79,201,236,243,264],"safety":[23],"muramyl":[25,49,136,152,173,234],"peptide":[26,50,137,153,174,235],"-":[27],"ligand":[29],"receptors":[32],"innate":[34],"immunity":[35],"(drug":[36],"Licopid\u00ae,":[37],"AO":[38],"Peptek,":[39],"Moscow,":[40],"Russia)":[41],"patients":[43,53,115,133,252],"psoriasis.":[45,165],"effect":[47],"on":[51],"86":[52],"different":[55],"severity":[56,261],"plaque":[58],"psoriasis":[59,84,254,263],"tested.":[61],"Area":[64],"Severity":[66],"Index":[67],"(PASI),":[68],"cytokine":[69],"status":[70],"production":[72],"nitric":[74],"oxide":[75],"blood":[77],"serum,":[78],"subsequent":[81,144],"course":[82],"have":[85,269],"been":[86],"evaluated.":[87],"Evaluation":[88],"significance":[90,271],"observed":[92],"differences":[93],"presented":[95],"by":[96],"Student's":[98],"t-test.":[99],"As":[100],"result":[102],"treatment,":[105],"cure":[107],"or":[108],"improvement":[109],"detected":[111],"98.2%":[113],"(p":[116,221,245],"<":[117],"0.05)":[118],",":[119],"while":[120],"24.4%":[121],"had":[122],"complete":[124],"cure.":[125],"Subsequent":[126],"observations":[127],"during":[128],"four":[129],"years":[130],"showed":[131,169],"that":[132,170,238],"who":[134],"received":[135],"statistically":[138],"significantly":[139],"increased":[140],"relapse-free":[141],"period.":[142],"Moreover":[143],"relapses":[145],"after":[149],"treatment":[150],"were":[154],"much":[156],"more":[157],"milder":[158],"form":[159],"cases":[162],"mild":[164],"conducted":[167],"studies":[168],"monotherapy":[171],"stopped":[175],"manifestations":[178],"psoriasis,":[180],"normalized":[181],"processes":[183],"cytokine-dependent":[185],"(interleukin":[186],"(IL)":[187],"-4,":[188],"IL-10,":[189],"IL-12,":[190],"tumor":[191],"necrosis":[192],"factor":[193],"alpha":[194],"(TNF-\u03b1))":[195],"regulation":[196],"response":[200],"nonspecific":[202],"resistance,":[203],"expressed":[204],"decreasing":[207],"amount":[208],"serum":[210,250],"antigens":[211],"sCD54":[212,242],"(soluble":[213],"intercellular":[214],"adhesion":[215],"molecule-1":[216],"(sICAM-1))":[217],"reference":[219],"values":[220],"\u2264":[222,246],"0.01).":[223],"Taken":[224],"together,":[225],"our":[226],"research":[227],"demonstrated":[228],"effectiveness":[230,275],"therapy":[232],"moreover,":[237],"elevated":[239],"levels":[240],"MIF":[244],"0.01)":[247],"considered":[255],"as":[256],"potential":[257],"biomarkers":[258],"control":[265],"over":[266],"their":[267],"dynamics":[268],"prognostic":[270],"determining":[273],"therapy.":[278]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2952907976","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2019-06-27T00:00:00"}
